Antiplatelet agents for chronic kidney disease-Reference-Cited by-同舟云学术

Antiplatelet agents for chronic kidney disease

Published:2022-02-28 Issue:2 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Natale Patrizia¹²³,Palmer Suetonia C⁴,Saglimbene Valeria M¹²,Ruospo Marinella¹²,Razavian Mona⁵,Craig Jonathan C²⁶,Jardine Meg J⁷,Webster Angela C²⁸,Strippoli Giovanni FM¹²⁶

Affiliation:

1. Department of Emergency and Organ Transplantation; University of Bari; Bari Italy

2. Sydney School of Public Health; The University of Sydney; Sydney Australia

3. Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences; University of Foggia; Foggia Italy

4. Department of Medicine; University of Otago Christchurch; Christchurch New Zealand

5. Renal and Metabolic Division; The George Institute for Global Health; Newtown Australia

6. Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia

7. NHMRC Clinical Trials Centre; Camperdown Australia

8. Centre for Transplant and Renal Research, Westmead Millennium Institute; The University of Sydney at Westmead; Westmead Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference686 articles.

1. Aspirin treatment in primary cardiovascular prevention and renal disease progression in CKD patients: a randomized clinical trials (AASER study) [abstract no: FR-PO1065];Goicoechea;Journal of the American Society of Nephrology,2017

2. Aspirin for primary prevention of cardiovascular disease and renal disease progression in chronic kidney disease patients: a multicenter randomized clinical trial (AASER Study);Goicoechea;Cardiovascular Drugs & Therapy,2018

3. Low dose aspirin increases 15-epi-lipoxin a4 levels in CKD patients [abstract no: SA-PO186];Goicoechea;Journal of the American Society of Nephrology,2017

4. Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients;Goicoechea;Prostaglandins Leukotrienes & Essential Fatty Acids,2017

5. Oral prostacycline analog and clopidogrel combination provides early maturation and long-term survival after arteriovenous fistula creation: a randomized controlled study;Abacilar;Indian Journal of Nephrology,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical Management of Coronary Artery Disease in Patients with Chronic Kidney Disease;The American Journal of Medicine;2023-12

2. Platelet disorders in uremia;Die Nephrologie;2023-09-21

3. Contemporary secondary prevention in survivors of ST-elevation myocardial infarction with and without chronic kidney disease: a retrospective analysis;Clinical Kidney Journal;2023-09-04

4. Computational drug repositioning of clopidogrel as a novel therapeutic option for focal segmental glomerulosclerosis;Translational Research;2023-09

5. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes;European Heart Journal;2023-08-25